Nav: Home

Cancer in the oldest old: The fastest growing age group in the US

August 07, 2019

A new report looks at cancer in adults 85 and older and finds incidence and mortality trends are generally similar to those in people 65 to 84, but screening is unexpectedly high and survival is poorer. The report appears in the American Cancer Society journal, CA: A Cancer Journal for Clinicians.

Adults aged 85 years and older - the "oldest old" - are the fastest-growing age group in the United States, yet relatively little is known about their cancer burden. To learn more, American Cancer Society investigators led by Carol DeSantis, MPH, and supported by leading geriatric oncology experts from City of Hope, University of Rochester Medical Center, and Duke University Medical Center, analyzed data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the National Center for Health Statistics to provide comprehensive information on cancer occurrence in this population.

In 2019, there will be approximately 140,690 cancer cases diagnosed and 103,250 cancer deaths among the 85 and older population in the United States. The most common cancers in these individuals -lung, breast, prostate, and colorectum--are the same as those in the general population. Overall cancer incidence rates peaked in the oldest men and women around 1990 and have subsequently declined, with the pace accelerating during the past decade. This progress reflects declines in cancers of the prostate and colorectum, and more recently lung among men and breast among women.

Among men 85 and older, prostate and lung cancers are the most common causes of cancer death, accounting for 40% of cancer deaths. Among women, lung cancer is the leading cause of cancer death (19%) followed by breast cancer (13%). For men and women, colorectal cancer is the third leading cause of cancer death, representing 9% and 12% of cancer deaths, respectively, in this population.

The authors also note that patients aged 85 years and older are less likely to be diagnosed at an early stage compared to those aged 65 to 84. For example, 57% of breast cancers in the oldest old are diagnosed at a local stage versus 68% in patients 65-84 years; for prostate cancer it is 41% compared to 77%, respectively. Late stage at diagnosis among the oldest old partly reflects less screening, which is generally not recommended for those aged 85 years and older because of diminished life expectancy, the higher prevalence of other serious medical conditions, and limited evidence of survival benefit. For most individuals in this age group, the small potential benefit of extending life is outweighed by the possible harms from screening, which increase with age.

Despite these recommendations, data from the National Health Interview Survey indicate unexpectedly high rates of screening in adults aged 85 years and older. In 2015, more than one-third of women aged 85 years and older reported receiving a mammogram within the previous two years, and 18% reported receiving recent cervical cancer screening tests. More than one-half of adults aged 85 years and older reported receiving either a stool screening test within the past year or a sigmoidoscopy or colonoscopy within the past five to ten years. Nearly 30% of men in this age group reported receiving a PSA test within the past year.

People 85 and over are also less likely to receive surgical treatment; only 65% of breast cancer patients aged 85 years and older received surgery compared with 89% of those aged 65 to 84 years. This difference partly reflects the complexities of treating older patients, including the presence of multiple comorbidities, functional declines, and cognitive impairment, but also highlights potential undertreatment of otherwise fit older adults. Overtreatment of vulnerable individuals in this age group is also a concern. The authors note that, importantly, age alone does not predict life expectancy, physical function, or the ability to tolerate treatment and provide information about tools to enable clinicians to evaluate the functional age of patients as part of the treatment decision-making process.

"More research on cancer in the oldest Americans is needed to improve outcomes and anticipate the complex health care needs of this rapidly-growing population," write the authors. "The rapid growth and diversification of the population aged 85 years and older will increase demand and complexities for cancer care and could have a substantial impact on medical care resource allocation. There is an urgent need to develop a more comprehensive evidence base to guide treatment decisions for these understudied patients with cancer through increased enrollment in clinical trials and to leverage research designs and infrastructure for generating evidence on older adults with cancer."
Article: Cancer Statistics for Adults Aged 85 Years and Older, 2019; Carol E. DeSantis, MPH; Kimberly D. Miller, MPH; William Dale, MD, PhD; Supriya G. Mohile, MD, MS; Harvey J. Cohen, MD; Corinne R. Leach, PhD, MPH, MS; Ann Goding Sauer, MSPH; Ahmedin Jemal, DVM, PhD. Rebecca L. Siegel, MPH. CA Cancer J Clin 2019; doi: 10.3322/caac.21577.

URL upon publication:

American Cancer Society

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at